Hoese & Co’s CVS Health CVS Stock Holding History

Hoese & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$8.35K	–	172
2023 Q1	$8.35K	Hold	100	–	–	0.01%	132
2022 Q4	$10K	Sell	100 -31	-24%	-$2.99K	0.01%	131
2022 Q3	$12K	Hold	131	–	–	0.01%	124
2022 Q2	$12K	Hold	131	–	–	0.01%	126
2022 Q1	$13K	Hold	131	–	–	0.01%	133
2021 Q4	$14K	Hold	131	–	–	0.01%	129
2021 Q3	$11K	Hold	131	–	–	0.01%	138
2021 Q2	$11K	Buy	+131	New	+$10.7K	0.01%	140

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Hoese & Co's CVS Position: Q2 2023 in Review

Hoese & Co sold out of CVS Health (CVS) in Q2 2023, closing a stake of 100 shares — an estimated $8.35K sold.

Hoese & Co first reported a position in CVS in Q2 2021 and held it in 8 quarters. The position peaked at $14K in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

Hoese & Co reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
Hoese & Co sold 100 CVS Health shares in Q2 2023, an estimated $8.35K.
Hoese & Co first reported a position in CVS Health in Q2 2021 and held it in 8 quarters.
Hoese & Co's CVS Health position peaked at $14K in Q4 2021.
2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Hoese & Co's 13F filing for Q2 2023, filed 12 Jul 2023.